A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
暂无分享,去创建一个
L. Raez | B. Childs | J. Wade | R. T. Webb | E. Santos | M. Karr | R. A. Brito | Andra Kennah